header
  Search CBBS Website

TRALI after IV anti-D (RhIg)

A transfusion medicine physician in Israel reports having recently seen a nulligravid 15 year old girl with refractory ITP who was treated by her pediatric hematologist with IV anti-D at a dosage of 50 mcg/kg. Four hours after receiving the anti-D she complained of weakness, chills and dyspnea. In an ER she had an O2 saturation of 88%, tachycardia, crackles over both lung bases and mild bilateral pulmonary infiltrates on chest xray. A cardiac echo was normal and she had minimal hemolysis (a drop of 1 g/dL hemoglobin over the following 48 hours with no overt intravascular hemolysis). She was treated with supplemental O2 by nasal prongs only. Within 24 hours the clinical syndrome had abated and O2 sat and xray were normal. The Israeli colleague is entertaining the possibility of TRALI, but wonders if other colleagues have suggestions for an alternative diagnosis. He asks two questions:

  1. Do others have experience with diagnosing TRALI following administration of IV anti-D for treatment of ITP?

  2. Could anybody help him with analysis of serum collected from the patient after she developed this complication, and a vial of anti-D from the batch that she received? He laments that he does not have facilities to test for white cell (neutrophil, monocyte, HLA) antibodies.

The following comments have been received.

1. A transfusion medicine physician in Irvine, California submits references to previously reported cases of TRALI after IVIg:

ADDENDA Sept 29, 2004

2. A colleague in the USA reports that she is aware of two granulocyte testing laboratories in the USA and one in Europe.

In the USA:

In the UK:

  • A National Blood Service laboratory in Bristol UK, The contact person is Geoff Lucas; phone 0117-991-2129.

3. A colleague in Europe believes that the laboratory of Jürgen Bux in Hagen, Germany, may also be able to help the Israeli physician.

4. A colleague at the Red Cross in Australia reports that they have a team with particular interest in TRALI, and expertise in neutrophil immunobiology. Contact information: Lin Fung, Granulocyte Scientist, The Innovation Laboratory, Knowledge & Innovation, ARCBS, Tel: 61-7-3833 1652 or 3835 1310, Fax: 61-7-3832 6025.

Printable PDF of this page

Please submit comments to the e-Network Forum.

Ira A. Shulman, MD
CBBS e-Network Forum Editor & Moderator

Posted: September 21, 2004

Addenda: Sept. 29, 2004

Link Fix: Oct. 25, 2004

The e-Network Forum is supported in part by the California Blood Bank Society (CBBS) and the American Red Cross Blood Services (ARCBS) and endorses collegial discussion among blood banking and transfusion medicine professionals. However, neither the CBBS nor the ARCBS in any way endorse the specific views and opinions expressed in the forum. The forum is not intended as a substitute for medical or legal advice and the content should not be relied upon for any medical or legal purposes. Readers should make their own determinations as to: (i) what constitutes appropriate medical, technical, and administrative practices, and (ii) how best to comply with laws and regulations relevant to their questions. For the latter, they should consider consulting, as to any medical matters, a qualified physician, and, as to any legal matters, an attorney familiar with related state and federal laws. The user of the forum, by accessing same, assumes all risks arising out of such use and releases CBBS and their respective members, directors, officers and agents from and against any loss, damage, claim or liability arising out of such use of the Forum.